Evidence map›Paper›PMID 35677841›Full record

ArticleExpert systems with applications2022

Intelligent model for contemporary supply chain barriers in manufacturing sectors under the impact of the COVID-19 pandemic.

Abduallah Gamal, Mohamed Abdel-Basset, Ripon K Chakrabortty

Abstract read
In one paragraph

Article in Expert systems with applications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Abduallah GamalFaculty of Computers and Informatics, Zagazig University, Zagazig, Sharqiyah 44519, Egypt.
Mohamed Abdel-BassetFaculty of Computers and Informatics, Zagazig University, Zagazig, Sharqiyah 44519, Egypt.
Ripon K ChakraborttyCapability Systems Centre, School of Engineering and IT, UNSW Canberra, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic has cast a shadow on the global economy. Since the beginning of 2020, the pandemic has contributed significantly to the global recession. In addition to the health damages of the pandemic, the economic impacts are also severe. The consequences of such effects have pushed global supply chains toward their breaking point. Industries have faced multiple obstacles, threatening the fragile flow of raw materials, spare parts, and consumer goods. Previous studies showed that supply chain barriers have multi-faceted impacts on industries and supply chains, which demand appropriate measures. In this regard, seven major barriers that directly impact industries have been identified to determine which industry is most affected by the COVID-19 pandemic. This paper utilized a hybrid multi-criteria decision-making (MCDM) approach under a neutrosophic environment using trapezoidal neutrosophic numbers to rank those barriers. The Analytical Network Process (ANP) quantifies the effects and considers the interrelationships between the determined barriers (criteria) involved in decision-making. Subsequently, the Measurement Alternatives and Ranking according to the COmpromise Solution (MARCOS) method was adopted to rank six industries according to the impact of those barriers. Results show that the lack of inventory is the largest barrier to influencing industries, followed by the lack of manpower. Sensitivity analysis is performed to detect the change in the rank of industries according to the change in the relative importance of the barriers.

Indexed as

ANPCOVID-19MARCOSMulti-Criteria Decision-MakingSupply chainUncertainty

Identifiers

PMID35677841
PMCPMC9162985

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.